The platform, which is available to Premier Pet Care Plan and Animal Healthcare clinics, is designed to help practices increase the number of sign-ups to health care plans.
Romain Regnier (pictured right), PVA’s Business Analyst Manager said: "The current situation has accelerated the need for a digital transformation.
"To help vet practices reach this goal, we have created a highly customisable digital sign-up solution, which mirrors the practice’s branding and can be used in communications to the customer, giving you more possibilities to promote your plans."
With a digital platform, practices can now encourage owners to sign up whilst waiting - socially distanced - outside, or from home.
Debbie Saunders, PVA’s Customer Experience Manager said: "It’s a two-pronged solution; reducing the impact that limited interactions with clients is having on health care plan signs ups and allowing practices to advertise their plans more efficiently.
We are encouraging practices to post about their new digital sign-up links on social media, so pet owners complete their forms anywhere. It will make a big difference to veterinary staff, reducing the amount of administrative pressure from plans but also allowing a direct call to action from advertising."
Each practice will be given unique urls, tiny urls and QR codes which link to the platform, alongside additional marketing materials. The marketing packs contain some customisable content, including social media assets, website banners and printable posters, all free to use to promote the new sign-up platform.
The digital sign-up platforms come with personalisation options, allowing practices to customise their webpage with their own logos, text, and branding, with the help of their PVA trainer.
If you are a Premier Pet Care Plan or Animal Healthcare clinic and are interested in integrating a digital sign-up form into your practice, contact your PVA trainer or call 0117 370 0300 .
The new service is led by Virginia Crespo DVM PGDip MSc MRCVS and Alex Hamilton BA VetMB MRCVS, pictured right.
Virginia qualified in 2012 from the Autonomous University of Barcelona, where she also served a rotating internship before completing an internship in neurology and neurosurgery at the Animal Health Trust in 2016. She finished a three-year residency in neurology and neurosurgery at Langford Veterinary Services in July, alongside attaining a Master’s of Science degree with Bristol University.
Alex graduated from Cambridge University in 2005 and after five years working in both mixed and emergency and critical care practice, he completed a surgical internship at the Animal Referral Hospital, Sydney, in 2012. He then completed a European accredited neurology residency at Melbourne University and Willows Veterinary Centre, in Solihull, and has since worked in Australia and the UK as a neurologist.
Clinical director Duncan Barnes said: “We’re delighted to welcome Virginia and Alex to Eastcott to lead this new service.
"They will provide in-depth consultations and neurological assessments alongside a variety of advanced diagnostic procedures to identify the problem and prepare an appropriate treatment plan.
"Virginia and Alex will have access to Eastcott’s new 1.5T MRI scanner and the clinic’s CT scanner, as well as electromyography, to assess the function of the nerves and muscles, and cerebrospinal fluid analysis.
"They will also work closely with another new recruit, Nicholas Taylor, who has joined us as referral radiographer, and other specialists across the hospital as part of a holistic approach to patient care."
For more information visit www.eastcottreferrals.co.uk.
In a European first, Pfizer Animal Health is conducting a major study in over 2000 dogs with Trocoxil, its new NSAID which delivers continuous analgesia for a month.
According to the company, Trocoxil has already been granted a licence by the EMEA and pre-authorization studies have already shown once-monthly Trocoxil to be at least as safe and effective as daily carprofen. However, the monthly dosing regimen represents such a big step from the currently used approach of daily NSAID dosing, that Pfizer has decided to initiate the study before launching the product in order to closely monitor and manage the introduction of Trocoxil to the veterinary market.
Jolian Howell, Associate Director Companion Animal Marketing for Pfizer said: "A drug with such a unique dosing regimen should be introduced in a controlled and managed way, and this study is part of that commitment by Pfizer Animal Health."
This large post-approval study, conducted under veterinary control as a User Experience Study, will enable a similar comparison with carprofen to be made in a much larger patient population. In fact it will be sufficiently large to provide product-specific safety information, such as any differences in the incidence of side-effects.
The randomised, parallel group study is being conducted in more than 100 veterinary clinics throughout France, Germany and the UK. Each dog will receive up to 6 months of treatment during which time it will be assessed every month by the veterinary surgeon.
Trocoxil, a preferential COX-2 inhibitor, has a unique pharmacological profile which means that a single oral dose provides continuous pain relief for a whole month.
Jolian added: "This study will provide veterinary surgeons with an opportunity to experience the benefits of using Trocoxil to treat OA continuously over a period of months. It will also give them the opportunity to assess the benefits this offers the owner."
The Privy Council has overturned an RCVS Disciplinary Committee to strike Leeds-based Dr Gary Samuel MRCVS from the Register following his conviction for theft, common assault and a public order offence at Cardiff Magistrates' Court in November 2011.
The Disciplinary Committee had agreed the sanction following a hearing in February 2013, at which it decided that Dr Samuel's conviction made him unfit to practise veterinary surgery.
Dr Samuel appealed the decision and the Privy Council heard the case on 26th March.
Dr Samuel had been sentenced by Cardiff Magistrates' Court to concurrent terms of 28 days' imprisonment for theft and common assault and 12 weeks' imprisonment for the public order offence, all suspended for 12 months. He had also been ordered to carry out 140 hours' unpaid work and to pay compensation of £75 and costs of £625. The charges related to an incident involving Dr Samuel and his neighbour, described by the Privy Council as "a spontaneous outburst in the course of an angry quarrel between neighbours", for which it felt that the Disciplinary Committee's sanction of removal from the Register was "disproportionately severe."
The Privy Council felt that, in making its decision, the Disciplinary Committee followed too closely the verdict reached by the Magistrates' Court, and did not take mitigating circumstances sufficiently into account, including whether the attack by Dr Samuel on his neighbour had been provoked by racial abuse.
Delivering the Privy Council's judgment, Lord Toulson said: "It is apparent from the reasons given by the Committee, both on the question of fitness to practise and on the question of sanction, that it was considerably influenced by the fact that the magistrates imposed a suspended prison sentence.
"Although Dr Samuel pleaded guilty to the theft of the camera and he was not in entitled to go behind his plea, it is nevertheless difficult to understand on the evidence how the prosecution would have proved that there was an intent permanently to deprive [the victim] of it. In all the circumstances, it is hard to conceive that the court would have considered that the offences truly passed the custodial threshold for a person of good character, if it had not had the power to suspend the sentence... Dr Samuel's conduct was thoroughly reprehensible, but the Board [Privy Council] does not consider that its gravity was such that it would be in the interests of the public now to remit the case to the Committee".
Dr Gary Samuel will not now be removed from the Register
The Privy Council's judgment can be read in full at http://jcpc.uk/decided-cases/index.html
Eurovet Animal Health has announced that it is bringing a veterinary licensed vitamin K1 (phytomenadione) injectable preparation to the UK.
Eurovet says the new preparation, available from the wholesalers by Monday at the latest, will ensure that the previous supply problems of vitamin K1, will be overcome.
According to the company, the intravenous route is the only route to ensure a 100% bioavailability of vitamin K1 almost immediately and in a crisis situation is the best route of treatment. During anticoagulant poisoning, the coagulation factors are present in the body but are not functional. The faster vitamin K1 enters the blood flow, the quicker the coagulation function is restored.
Ruth Vernon, Technical Services Manager for Eurovet said: "We also plan to bring veterinary licenced vitamin K1 tablets to the UK market later in the year, allowing them to be ordered direct from veterinary wholesalers. The future continuity of supply represents a significant improvement on the current situation."
Anticoagulant rodenticide poisoning is the second most common query received by the VPIS. Alexander Campbell, Head of Service at VPIS, said: "The Veterinary Poisons Information Service receives well over 1000 telephone enquiries per annum from UK veterinary professionals seeking advice on how to manage potential and accidental exposures to anticoagulant rodenticides in a variety of animals - mainly pet dogs. Whilst most cases require basic assessment, first-aid and precautionary laboratory tests, an inevitable few develop serious intoxication and need long-term treatment. Vitamin K1 is a mainstay of therapy in these instances, and the availability of licensed veterinary-specific products in the UK is a major advance. Previously, preparations licensed for human use were often the only option when these could be sourced. Anything that ensures ready supply and facilitates speed of therapy for severe cases has to be welcomed."
There are over 500 anticoagulant rodent killing preparations available across Europe. They are available ready to use, as coated cereals, bait blocks, tracking powders, semolina formats or concentrates (which are reserved for professional use). Following cut backs in local council spending on pest control, the National Pest Technicians Association identified in a recent survey* that there is a 'worrying increase in poorly-managed DIY rodent control'.
*The NPTA National Rodent Survey 2009/2010
Elanco Companion Animal Health has launched a competition to encourage veterinary professionals to showcase the company's new range of practice support materials for the company's parasiticides, Comfortis and Trifexin.
To enter the competition, you'll first need to order the support materials, which include: waiting room posters, client leaflets and a waiting room leaflet dispenser, modular window hangers, social media artwork and display kits which consist of 19 die-cut colour pieces for waiting room displays. Entry / order forms are available here.
Then create your display and email a digital photograph of it to Elanco before the 29th August 2014.
Matthew Rowe, Senior Brand Manager at Elanco said: "We're asking veterinary practices to use their creativity and imagination when putting up their parasite control displays. Last year's winner, the Animal Health Centre in Torquay, even composed their own song, so the more creative the better!"
The overall winner will win a team celebration worth £1000, and there are £250 Amazon vouchers for 11 regional winners.
For further information contact your local Elanco Companion Animal Health key account manager or email elancocahuk@elanco.com
In the UK, the product is marketed under the brand names Vetofol and Inductofol.
An issue of coring has been reported, where the shearing off of a portion of the 20mm bromobutyl bung occurs as the vial is pierced to withdraw the product. This may result in particles from the bung entering the product and potentially being drawn up into the syringe upon extraction of the product from the vial. It may also result in the bung not resealing fully after use.
If you have any queries in relation to the recall or require details of the product in other markets, contact Mrs Deborah Curran Tel. +4428 30264435 or email deborah.curran@norbrook.co.uk.
Stefano qualified in Parma, Italy and has a Master’s in Clinical Oncology. He has worked in a number of referral practices, managing and treating small animal oncological cases. He also has an interesting history of working with animals across the globe: he has a Master’s in Tropical Veterinary Medicine and worked with the United Nations in Somalia, Malaysia and Guyana in wildlife management.
Founder, CEO and Clinical Director of The Ralph, Shailen Jasani said: "We had always planned to include an oncology service here at The Ralph though not quite this soon after opening. However, over the last eight months, this has been one area of veterinary medicine where we have not been able to serve our patients, their carers or our referral community. This did not sit well with us. Serendipity being what it is, our path crossed with Stefano's and we were able to extend our services."
For more information, visit www.theralph.vet
The authors say that the prognosis for dogs with stage II Kiupel high-grade cutaneous mast cell tumours has historically been considered poor.
However, the removal of metastatic regional lymph nodes in more recent research has been associated with a better outcome in canine cutaneous mast cell tumours.
For this study1, dogs with a histological diagnosis of overt lymph node metastasis that underwent lymphadenectomy (n = 31) were compared with those with a cytological diagnosis of regional lymph node metastasis, that did not undergo excision (n 18).
The study was a multi-institutional retrospective cohort study, using electronic medical records from four European institutions to identify dogs for inclusion.
The study found that dogs with Kiupel high-grade cutaneous mast cell tumours undergoing lymphadenectomy of HN3 lymph nodes as part of their primary surgery in addition to adjuvant medical treatment had a significant improvement in time to progression and survival time compared with those dogs not undergoing the procedure.
Lack of lymphadenectomy was the only variable significantly associated with a higher risk of nodal progression.
Dogs underwent lymphadenectomy of one peripheral lymph node in most cases.
The authors says that a higher number of lymph nodes or the removal of intracavitary lymph nodes might be associated with an increased incidence of postoperative morbidity.
They add that the findings warrant further exploration of the effect of surgical extirpation of metastatic sentinel lymph nodes and the number of lymph nodes removed on outcome in dogs with Kiupel high-grade cutaneous mast cell tumours.
Nicola Di Girolamo, Editor of JSAP said: “It is really encouraging to see collaborations from multiple institutions like the study presented here.
"Including multiple institutions in a retrospective cohort study, does not only ensure a higher sample size, but also ensure a higher generalisability of the results.
"Meaning that it is more likely that the differences observed in this study are also going to be observed at different practices and with different clinicians.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13525
Reference
Once a month, a new discussion will be posted by the site editor titled: "WHAT WOULD YOU DO (in xxx clinical situation)?"
In addition, VetSurgeon members are strongly encouraged to start your own "WHAT WOULD YOU DO?" discussion at any time.
All members are then invited to share what they would do for the case described, and we also use the opportunity to question which approach offers the best value for pet and owner, and brainstorm new ways of approaching the problem.
Importantly, criticising (as opposed to questioning) anyone's approach is strictly forbidden.
The aim is to share what most vets are doing, question whether there are better ways of doing things and brainstorm fresh ideas, something which is always a beneficial but perhaps especially so in a cost-of-living crisis when, for a variety of reasons, veterinary fees have escalated above and beyond inflation.
As a result, it has become increasingly important to question, for example, the value of certain diagnostics and whether a different approach could offer clients more value.
By way of example, the first discussion was: "WHAT WOULD YOU DO: cat over-grooming central abdomen?", which you can read and take part in here: https://www.vetsurgeon.org/f/clinical-questions/30842/what-would-you-do-cat-over-grooming-ventral-abdomen
The second discussion is now live, and asks: "WHAT WOULD YOU DO: Young dog presented having had its first single or cluster of seizures?
Come and share your thoughts here: https://www.vetsurgeon.org/f/clinical-questions/30875/what-would-you-do-young-dog-presented-having-had-its-first-single-or-cluster-of-seizures
Full rules here: https://www.vetsurgeon.org/f/clinical-questions/30841/what-would-you-do-discussions-rules-and-objectives
The charity, which was set up over 120 years ago, says the number of calls and emails it gets from industry professionals seeking help has increased 500% over the last 5 years; it has received more than 1,500 calls and emails over the past 12 months.
Lynne Hill, Chief Executive of Linnaeus said: "The veterinary industry is fast-paced and, at times, an extremely stressful environment, so the support on offer from Vetlife is particularly valuable and its worth is demonstrated by the significant increase in contact being made to it.
"We hope this donation will help Vetlife continue to provide the excellent service and support they have given to vets and nurses for so long."
Vetlife President Geoff Little said: "This donation from the Linnaeus Group is extremely generous. We have seen a dramatic rise in calls and emails to the service over recent years. So much so, we have recruited additional volunteers to cope with the additional contacts. It’s extremely gratifying to see the number of volunteers who are so willing to put something back into their profession and to help others.
"At Vetlife, we provide support in the shape of three core services, which are the Vetlife Helpline, which provides independent, confidential support 24/7, 365 days a year; Health Support, run by mental health professionals; and Financial Support, which provides assistance to vets or their dependents who find themselves in difficulty.
"This support from Linnaeus will help us to bridge the gap as the need for support continues to grow."
Anyone who needs support can contact the Vetlife Helpline on 0303 040 2551 or anonymously via www.vetlife.org.uk.
Photo: Vetlife President Geoff Little receives the £60,000 donation from Lynn Hill at Linnaeus.
The pads contain ophytrium and chlorhexidine at 3%. Ophytrium is a purified natural ingredient from Ophiopogon japonicus which, Ceva says, strengthens the mechanical skin barrier1, restores the balance of protective microbial flora2 and reduces irritation, while soothing the skin1. Chlorhexidine is both antibacterial and antifungal.
Ceva says that Douxo S3 Pyo pads, which come in packs of 30, provide antibacterial and antifungal efficacy within one minute and are free from soap, parabens, sulphates, phthalates, colourants and nanoparticles.
They are available in a new, hypoallergenic ‘summertime’ fragrance which pet owners liken to coconut and vanilla.
The pads add to the Douxo S3 Pyo range, which also consists of shampoo and a mousse.
Andrew Fullerton BVSc (Hons) MRCVS, product manager for Douxo S3 at Ceva said: "The new Douxo S3 range has been well received by both veterinary professionals and their clients since its launch, who find that the products are not only effective and well tolerated, but also easy-to-use. The Douxo S3 Pyo pads will enhance this range by offering an easy-to-administer antiseptic action while hydrating and maintaining the skin’s ecosystem.”
For further information, contact cevauk@ceva.com, your local territory manager or visit https://www.douxo.com/uk/Pet-Skin-Care/douxo-s3.
References
Pete (pictured right), an RCVS Recognised Specialist in Veterinary Dentistry, was recognised for his outstanding contributions to the discipline of veterinary oral and maxillofacial surgery (OMFS).
There are a total of 14 founding fellows and Pete is the only one practising in Europe. The award will mean it’s possible for an OMFS Fellowship programme to be delivered at Eastcott Referrals in the future.
Pete said: "To be accepted as an AVDC Fellow is a real honour and I’m delighted to be awarded this position. There is a pretty rigorous process to go through to become a Founding Fellow of the AVDC, so it’s extremely gratifying to be recognised."
At the same time, another Eastcott clinician is also celebrating recognition in the same discipline: Andrew Perry has become a European Veterinary Specialist in Dentistry.
Pete said: "We all congratulate Andrew on his achievement. He is a hugely valuable and experienced member of the team here.
"It’s a very exciting time for Eastcott, as we seek to expand our dentistry and oral and maxillofacial surgery department and develop new techniques in OMFS.
"We have a highly experienced team and will adding another Resident in the new year, so we’re in an extremely strong position to deal with a large caseload and able to see a wide range of different cases."
For more information about Eastcott Referrals, visit www.eastcottreferrals.co.uk.
Sheldon is managing director of RVC Veterinary Practices Ltd and principal at Acorn House Veterinary Hospital in Bedford. He has been with the practice for 14 years. A graduate of Cambridge University he has a particular interest and a GP Certificate in ophthalmology. He has been a member of the BSAVA Board for the past five years and a volunteer since graduation.
Sheldon says that during his Presidency he will focus on shaping Congress 2022 into the ultimate veterinary get-together as the country begins its release from the challenges and constraints of the pandemic. He said: "With more than 3,300 registrations, the turnout for and particularly the engagement with BSAVA Virtual Congress 2021 was phenomenal, given the challenges the profession is currently facing as a result of the pandemic.
“We intend to build on this for BSAVA Congress 2022, by deploying a cleverly blended format to retain the high degree of accessibility and flexibility that delegates have so enjoyed this year. We will be releasing further details on BSAVA Congress 2022 in the early summer.”
Sheldon says he will also be focusing on BSAVA’s support for the small animal veterinary community as it emerges from the pandemic.
"The profession has shown incredible resilience and dynamism in responding to the changing demands of our patients but we need to be careful that this is not at the expense of our own wellbeing. BSAVA’s community support, practical education and science resources and leadership are all there to support the profession as it pivots to a new way of working.”
BSAVA Virtual Congress 2021 content is accessible for another 6 weeks. Visit https://www.bsavaevents.com/bsavacongress2021/en/page/home.
The RCVS Disciplinary Committee has agreed to adjourn multiple charges against a County Durham-based veterinary surgeon following her undertakings to request removal from the RCVS Register and never to apply to be restored to it.
At the hearing held yesterday, Silke Birgitt Lindridge was charged with disgraceful conduct in a professional respect in regard to four separate allegations, spanning the period of June 2011 to September 2012 whilst in practice at the Safe Hands Veterinary Group. Two of the allegations related to failures to euthanase or arrange the euthanasia of a cat and a dog and being dishonest and/or misleading about these failures, with their respective owners. The other two allegations related to administering a vaccine (Fevaxyn) which was more than two years past its expiry date to a cat, and failure to provide or take adequate steps to provide promptly all the relevant clinical information to a veterinary practice taking over the responsibility for the treatment of a Labrador Cross.
However, before the Disciplinary Committee had heard evidence in respect of these charges, Mrs Lindridge, who did not attend the hearing, had lodged her application for adjournment on the basis that she would request that the Registrar remove her name from the Register with immediate effect and undertake never to apply to be restored to it. The Disciplinary Committee made no enquiry into the facts of the four charges and emphasised that they had neither been proved against, nor admitted by, the respondent.
Removal from the RCVS Register removes a veterinary surgeon's right to practise in the UK. The respondent informed the RCVS that she had no wish to return to the practice of veterinary surgery in this country. Should she subsequently apply to be restored to the Register, the Disciplinary Committee would resume its consideration of the charges, along with the breach of her undertaking.
The Disciplinary Committee was advised that the views of the animal owners involved had been sought and that all had agreed with the proposed course of action.
Speaking on behalf of the Disciplinary Committee, its Chairman, Professor Peter Lees, said: "Having considered the information before it, the Committee has decided it would not be in the public interest to proceed to a full hearing. It is satisfied that the undertakings offered by the respondent [Mrs Lindridge] protect the welfare of animals and uphold the reputation of the profession."
Professor Lees added: "The undertakings offered by the respondent to request the Registrar to remove her name from the Register with immediate effect and never to make an application for restoration to the Register, go beyond any sanction that this Committee could impose at the conclusion of a contested hearing. It does not consider that it would be proportionate for either party to incur the substantial costs of a contested hearing."
Having had a three-month sabbatical working at Fitzpatrick, Jonathan decided to relocate from New Zealand where most recently he'd been Head of the Companion Animal Group at Massey University.
Jonathan said: "My prime passion is working directly with animals and their families in a supportive and exceptional clinical setting. I enjoy pushing boundaries and not accepting the status quo. I want to identify better ways of improving outcomes for patients, and minimising the impact of the disease (or its treatment) on an animal’s quality of life. My sabbatical at Fitzpatrick Referrals exposed me to their tremendous energy and real passion for patient and client care. From the moment the clients walk in the door, I feel there is an embrace that lets people know we truly care and want to do the best for their animal friend. I am looking forward to discovering what we can achieve together. Cancer management is such an important opportunity, with the power to change both animal and human lives positively. The direction and focus of Fitzpatrick Referrals in this area is already incredibly exciting.”
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "On Jon’s first day of his sabbatical, he jumped right into the team and made an immediate positive impact. He hasn’t looked back. He carries with him such a good energy, which we all absorb and hopefully reflect back. His knowledge of implant design for dealing with defects in the mandible and elsewhere is exceptional and I am looking forward to watching that develop. I am also very pleased that Jon’s wife Sharyn is able to join the team; she is very experienced in the field of advanced imaging in humans, including Fluoroscopy and PET-CT. This is already benefitting our patients as we improve our diagnostic and treatment abilities, and get ready for the future."
Jonathan has active research interests in several clinical areas including soft tissue sarcoma, injection-site sarcoma, endoprosthetics and haemangiosarcoma. He also supports the concept of One Medicine as his PhD research into soft tissue sarcoma, haemangiosarcoma and endoprosthetics has a potential relevance in improving the understanding of treatment paradigms for humans and animals.
MSD says the new vaccine reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V), and that no other UK-licensed BRD vaccine can be administered earlier in life.
According to the company, it also delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. The duration of immunity is 12 weeks for both viruses.
MSD Animal Health ruminant veterinary adviser Dr Kat Baxter-Smith MRCVS said: "Early-age protection of calves through intranasal vaccination can help prevent pneumonia and positively impact a calf’s productive future.
"The sooner and faster these young calves can be protected against viral BRD and the permanent lung damage it causes, the better their potential lifetime productivity, be it in terms of delivering expected milk yield in the dairy herd or growth performance on the beef unit1 2."
Kat added that Bovilis Intranasal RSP Live also activates non-specific immunity – stimulating receptors and cytokines in the innate immune system3: "This equates to protection against viral replication in the nasopharyngeal cavity, reduction of virus shedding and protection of the calf against subsequent clinical symptoms3."
MSD says a practical benefit of Bovilis Intranasal RSP Live to farmers is that it can be used on farm up to six hours after mixing with the solvent, which is the longest of all the available intranasal BRD vaccines. Additionally, the new vaccine is supplied as a farm-friendly, easy-to administer nasal suspension product that doesn’t need a specific applicator – although for maximum flexibility a new easy-clean injector and nozzle kit is available for farmers needing to vaccinate multiple animals.
References:
Vetsonic UK has announced the addition to its range of Vetericyn Super 7+, a brand new umbilical cord dry-out solution for use in calves, lambs, piglets, foals, kids and puppies which is designed as an alternative to iodine.
Vetsonic says that because Super 7+ contains no iodine, it won't encourage licking by iodine-deficient mothers, which can cause serious damage to the navel. It is also an ideal alternative for handlers who are prone to iodine allergies.
The company points to a US study conducted by Auburn University in which Super 7 + demonstrated more than double the desiccation efficacy in the first 24 hours when compared to 7% tincture of iodine.
Super 7+ contains a dye for easy identification of treated animals and the company says it is environmental friendly, safe, non-flammable and non-corrosive with no toxic fumes.
Super 7 + is now available through veterinary wholesalers and direct from Vetsonic (UK) Ltd, either in a 500 ml spray bottle (box of 6) or a 3.78 litre bottle for dipping.
For more information, visit www.vetsonic.com
The company says that the 20 module medicine programme, covering all of the major body systems of cats and dog, combines the latest thinking in small animal medicine with its world-class learning resources to ensure that delegates’ learning experience online gives the same high-quality learning as the attendance programme.
Improve says it aims to offer a route for veterinary surgeons who don’t have the time to participate in an attendance programme or who work in countries where this type of training is not available, the opportunity to study for a recognised postgraduate qualification.
Delegates signing up for the programme will have a module tutor – an RCVS or ECVIM/ACVIM Small Animal Internal Medicine Diploma holder – and a dedicated programme tutor who works with individual delegates to ensure they are supported throughout the programme.
Improve says the course includes interactive and engaging modules, together with real-life case studies, presentations, written notes, interactive quizzes and exercises.
Dr Alison Babington MRCVS, Business Coordinator at Improve said: "The pressures on veterinary professionals today have never been more intense and many of us struggle to find the work-life balance which is so important for our well-being. Unfortunately, these pressures often preclude many vets from undertaking the type of postgraduate training which could give them additional job satisfaction and enhance both their career prospects and the profitability of their practice.
"It has been our ambition for some time to offer some of our flagship programmes online and, in creating the Distance Learning Small Animal Medicine programme, we drew on the experience of the latest online platforms.
"This new Distance Learning Programme offers a high quality interactive, engaging Small Animal Medicine learning experience which will be fun to study and a far cry from the days of simply reading text online. It will be accessible to vets working anywhere in the world and we’re very proud to be able to offer a high level programme via this learning route."
For more information visit: www.improveinternational.com or ring 01793 759159.
Idexx has launched Pet Resist (www.petresist.com), an online map of the levels of antibiotic resistance recorded in cats and dogs by the company over the past five years.
The map displays geographical variations in resistance to the top 10 antibiotics used in cats and dogs.
Simon Wootton, UK CAG Marketing Manager from Idexx said: "The ability to select the most appropriate antibiotic prior to testing may increase the effectiveness of treatments and reduce the number of return visits. We believe that this new service will also help prolong the effective life of existing antibiotics at a time when there is considerable pressure on the profession to reduce their use."
Pet Resist shows levels of resistance overlaid on an interactive UK map down to individual postcode areas. You enter the postcode, the antibiotic (amoxicillin, ampicillin, cefaliexn, etc) and the suspected organism (E coli, S aureus, etc), after which you'll be able to see the level of resistance based on historical data from the past five years, and use this to help choose appropriate therapies.
Simon added: "We have used results of MIC tests on over 200,000 samples submitted to Idexx to develop the database upon which the resistance levels are based. The data will be continually updated as we receive more samples at our Wetherby laboratory, further increasing the accuracy and value of the service to vets and their clients."
The new editorial team is comprised of Gareth Arthurs and Rob Pettitt, both RCVS Recognised Specialists in Small Animal Surgery (Orthopaedics) and Gordon Brown (no, not that one), an RCVS Diplomate in Small Animal Surgery (Orthopaedics).
Given the considerable evolution in the diagnosis, understanding and treatment options for many orthopaedic disorders, this second edition includes the investigation of lameness, including the use of force plates and kinematics, the current understanding of elbow dysplasia and the wide array of available treatment options, and diagnostic and surgical arthroscopy.
New, advanced surgical techniques, such as tibial osteotomy for cranial cruciate ligament disease, cementless total hip replacement for hip dysplasia and replacement of the trochlear sulcus for patellar luxation have been covered, together with guidance on the level of training and experience necessary to achieve consistently good results.
The manual is divided into four principle sections:
Lameness investigation
Musculoskeletal disorders
Principles of orthopaedic surgery
Management of specific disorders, ordered by individual joints.
The joint-specific chapters all follow a similar format, comprising the main chapter and then, where relevant, imaging and operative techniques.
Gareth Arthurs, one of three editors, said: "We feel privileged to have worked with such a broad range of talented authors whose combined international skills, knowledge and experience is impressive and very difficult to match. It has truly been a privilege to work with such a team of inspiring veterinary surgeons with expertise in various fields, and we are confident that the talent of each individual shines through their chapter".
The second edition of the BSAVA Manual of Canine and Feline Musculoskeletal Disorders is available from the BSAVA website: www.bsava.com or by phone: 01452 726700. The online edition is available from: www.bsavalibrary.com
PBD says Bovine tuberculosis (bTB) is a growing problem for zoos and wildlife parks, especially with the disease’s potential to spread from one species to another, creating a natural reservoir that is difficult to control.
bTB in zoos came to public attention last year when Devon’s Paignton Zoo detected a single case in one of its antelope. Without access to a test that would deliver rapid results, the zoo had to cull the remaining 10-strong herd of Kafue Flats lechwe.
PBD says the Actiphage test can identify bTB and other mycobacterial diseases in animals before clinical symptoms of infection are observed. It can detect with high specificity the presence of any mycobacteria in animal blood within 6 hours in comparison to culturing mycobacteria, which can take up to 12 weeks.
The technology has been successfully applied to blood samples from 17 different species so far, including deer, goats and badgers as well as exotic animals such as lions, giraffes, antelopes, elephants, tigers, kangaroos and camels. Trials have confirmed PBD Biotech’s assay can detect live mycobacteria in blood or milk samples at very high sensitivity, of less than 10 mycobacterial cells per ml of sample.
The test is being presented to delegates at the British Veterinary Zoological Society (BVZS) Congress in Birmingham today by Dr Ben Swift, Research Fellow at the Royal Veterinary College and R&D Director at PBD Biotech.
He said: "The Actiphage detection method provides a major step change in the detection of viable mycobacteria and has the potential to revolutionise the control and understanding of mycobacterial diseases in zoo animals, wildlife and a range of other species.
"The use of bacteriophage means the test can detect mycobacteria before an immune response is fully developed, giving vets, zoo-keepers and other exotics experts a head-start on the race to catch bTB and other diseases in the hope of preventing the unnecessary cull of protected animals."
Domingo, pictured on the left with Southfields clinical director Henry L’Eplattenier, will join the Essex referral centre as head of cardiopulmonary service at the start of February.
After qualifying in Zaragoza in his native Spain, Domingo completed an internship and several years in practice in the UK, before joining the University of Bristol small animal hospital as a resident.
He then completed a three-year training programme in small animal internal medicine, followed by a four-year programme in cardiology to become an RCVS diplomate and specialist in veterinary cardiology and small animal internal medicine (ECVIM).
After being appointed as head of cardiology and respiratory medicine at Bristol, Domingo joined Dick White Referrals before his move to Southfields.
Domingo said: "I’m delighted to be joining such a progressive and forward-thinking practice as Southfields. It is clear everyone at the practice is dedicated to continuing its growth and dedication to providing the highest possible level of care."
Southfields’ operations manager Daniel Hogan said: "The arrival of Domingo adds another hugely talented specialist to our growing team of experts. He is, without doubt, at the top of his profession and his passion and dedication are traits which will fit perfectly at Southfields as we continue to grow."
Domingo is also a visiting lecturer in cardiology and respiratory medicine at the Catholic University of Valencia, while he is an active clinical researcher and has published widely in many areas of cardiology and respiratory medicine. His areas of special interest are arrhythmias and interventional cardiology.
For more information about Southfields Veterinary Specialists, go to www.southfields.co.uk.
Amongst the speakers were Catherine Oxtoby MRCVS, Risk Manager at the Veterinary Defence Society, and Dr Huw Stacey, director of clinical services at Vets4Pets.
Dr Stacey explained how Vets4Pets and Companion Care practices are embracing a culture of sharing information when things don’t go according to plan in practice.
He said: "We all face challenges in the workplace, and this event focused on how different professions can share ideas and good practice and how they find solutions to any challenges.
"The culture of aviation and maritime is one of minimising risk and putting safety first, and it is fascinating to compare their approach to that found in medicine and veterinary.
"One common theme we discussed was the wellbeing of both professionals and patients or clients, with tiredness being at the top of the list of things that can negatively affect wellbeing and performance.
"Both aviation and maritime recognised that long shifts, particularly overnight, needed to be reduced in order to improve the outcome for everyone.
"In veterinary and human medicine, tiredness and long shifts are often worn as a badge of honour and being tired at work was something that should be admired, rather than addressed.
"But, tired vets are effectively neglecting themselves and their own wellbeing, which in turn leads to pets not receiving the best level of care in practice.
"This is something we’re taking seriously at Vets4Pets and Companion Care, and we’re currently looking at ways to decrease the risk of overworked and tired vets and vet nurses."
Another area of discussion was around the reporting of near misses and when things don’t go right, and how veterinary professionals need to identify and share the learnings from these events, not only within their practice, but with the wider profession too.
He said: "We need to continually emphasise the concept of a ‘just’ culture, to ensure our colleagues feel confident about reporting incidents open and honestly."
"It is not in the interests of the professional, the patient or the client to bottle things up, and at Vets4Pets and Companion Care we’re encouraging all of our practices to adopt the VDS VetSafe system, which provides a mechanism for sharing incident reports across the profession, enabling us all to learn from them to the benefit of our patients."
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.